Zen Medical Attends Industry Leading Addiction / Behavioral Health VIP Symposium II

MIAMI, June 19, 2015 /PRNewswire/ -- Zen Medical, LLC., a division of Sanomedics, Inc. (OTC:SIMH) announced today that it will be attending the Addiction / Behavioral Health VIP Symposium II, June 24-25 in Ft. Lauderdale, Florida at Inverrary Plaza Resort.

The Addiction / Behavioral Health VIP Symposium II is a nationally acclaimed conference for addiction and behavioral health professionals. This year's edition will include over 60 exhibitors and 250 attendees from across the country. Attendees will be educated in the latest developments in the industry, gain insight from top experts and engage in networking opportunities with leading professionals in addiction and behavioral health.

Zen Medical will showcase ZenCharts™, its best-of-breed Electronic Health Records (EHR) that offer quick access to patient records from multiple locations, improving the ability to diagnose diseases and reduce medical errors. The EHR system not only improves patient care but also increases practice efficiencies such as enabling electronic prescriptions and improving accuracy in coding and billing, which ultimately results in cost and time savings.

"ZenCharts offers addiction and care centers an invaluable opportunity to streamline their processes and improve operational efficiency allowing professionals to spend more time on focusing what is most important, the patient," said Keith Houlihan, President of Sanomedics. "Our commercialization strategy involves heavily targeting the newly defined and underserved addiction treatment center market. We are therefore excited to attend the Symposium as it will provide us with the right platform to educate industry professionals on the benefits of ZenCharts and increase brand awareness."

About Sanomedics, Inc.
Sanomedics, Inc. (OTC: SIMH) is an international medical technology company focused on developing, manufacturing, and acquiring cutting-edge technology, products and services. The Company operates mainly through its subsidiary, Thermomedics, which is dedicated to engineering, marketing and selling the Caregiver TouchFree™ Infrared thermometer. The Caregiver non-contact thermometer is FDA-cleared in the United States for clinical use by medical professionals. The Caregiver provides an accurate and expedited temperature reading without direct contact between patient and medical professional. Sanomedics has established an extensive distribution network with several leading healthcare supply chain providers to increase adoption of the Caregiver device within the medical community worldwide.

Forward Looking Statements
Statements in this press release regarding Sanomedics that are not historical facts are forward- looking statements and are subject to risks and uncertainties that could cause actual future events or results to differ materially from such statements. Any such forward-looking statements, including, but not limited to, financial guidance are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not directly or exclusively relate to historical facts. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "could," "would," "expects," "plans," "anticipates," "believes," "estimates," "projects," "forecasts," "predicts," "potential," or the negative of those terms, and similar expressions and comparable terminology. These include, but are not limited to, statements relating to future events or our future financial and operating results, plans, objectives, expectations and intentions. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these expectations may not be achieved. Forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject to known and unknown risks, uncertainties and other factors outside of our control that could cause our actual results, performance or achievement to differ materially from those expressed or implied by these forward-looking statements.

These forward-looking statements represent our estimates and assumptions only as of the date of this release and, except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this release. Given these uncertainties, you should not place undue reliance on these forward-looking statements and should consider various factors, including the risks described, among other places, in our most recent Annual Report on Form 10-K and in our Quarterly Reports on Form 10-Q, as well as any amendments thereto, filed with the SEC.

Investor Contacts:
Phil Carlson / Elizabeth Barker
KCSA Strategic Communications
212-896-1233 / 212-896-1203
[email protected] / [email protected]

Media Contacts:
Chloe Font / Andrew Herweg
KCSA Strategic Communications
212-896-1287 / 212-896-1273
[email protected] / [email protected]

SOURCE Sanomedics, Inc.